Practical issues in the management of novel oral anticoagulants-cardioversion and ablation

Area of Science:

• Cardiology
• Pharmacology
• Electrophysiology

Background:

• Novel oral anticoagulants (NOACs) are increasingly used due to benefits like specificity and predictable pharmacokinetics compared to warfarin.
• Landmark trials have led to the approval and adoption of NOACs in clinical practice.
• Emerging issues include appropriate selection, complication management, and use during procedures like cardioversion and catheter ablation.

Purpose of the Study:

• To review practical considerations for using NOACs in patients undergoing cardioversion and catheter ablation.
• To address the timing of anticoagulant interruption and re-initiation to balance thromboembolism and bleeding risks.
• To highlight special considerations based on individual NOAC properties and patient comorbidities.

Main Methods:

• Review of currently available data on NOAC use in electrophysiology.
• Discussion of pharmacological properties of individual NOACs.
• Consideration of comorbidities such as renal and hepatic impairment.

Main Results:

• NOACs offer advantages in anticoagulation therapy.
• Peri-procedural management of NOACs requires careful timing of interruption and re-initiation.
• Individual NOAC properties and patient comorbidities necessitate tailored approaches.

Conclusions:

• Practical considerations for NOAC use in cardioversion and catheter ablation are crucial.
• Balancing thromboembolic and bleeding risks is paramount in peri-procedural management.
• Individualized strategies are needed based on NOACs, procedures, and patient factors.